Pharma company, Lupin is set to announce its financial performance for the quarter ending December 2021 (Q3FY22) on February 3, 2022. On Wednesday, Lupin stock traded higher.
At around 12.08 pm, Lupin was trading at Rs947.65 per piece up by 0.5% on Sensex. The stock has touched an intraday high and low of Rs951 per piece and Rs933.80 per piece respectively.
In September 2021 quarter, Lupin logged a consolidated net loss of Rs2,094.9cr. The company had posted a profit of Rs213.1cr in Q2FY21 and Rs548cr in Q1FY22. Further, the company's total revenue from operations was at Rs4,091.3cr in Q2FY22 rising by 6.7% yoy but declining by 4.2% sequentially.
During the Q2 quarter, the company booked a provision of Rs1,879.6cr (including Rs38.7cr towards litigation and settlement related expenses) under Glumetza class actions towards business compensation expenses based on the agreement to settle the dispute with two plaintiff groups as well as Impairment expense of Rs707.7cr for Solosec.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.